ArticleACS medicinal chemistry letters2012

JAK Kinase Inhibitors as Possible Treatment for Myeloproliferative Disorders and Cancer: Patent Highlight.

Ahmed F Abdel-MagidPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.